On 4 January 2016, Check4Cancer launched a OneStop diagnostic breast network for Cigna insured clients via its BreastHealth UK brand. Professor Gordon Wishart, Chief Medical Officer and co-founder of Check4Cancer has conducted his own research which shows that performing all tests at the one appointment, including a biopsy if necessary, is the most effective way to make the best diagnosis, with an accuracy of 99.6%. Triple assessment has played a fundamental role in the diagnosis of breast lumps since the 1990’s and although it is an established, validated protocol for the investigation of patients with breast symptoms, it is not routinely available in the private sector.